JP1667072S - - Google Patents

Info

Publication number
JP1667072S
JP1667072S JPD2020-6113F JP2020006113F JP1667072S JP 1667072 S JP1667072 S JP 1667072S JP 2020006113 F JP2020006113 F JP 2020006113F JP 1667072 S JP1667072 S JP 1667072S
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JPD2020-6113F
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JPD2020-6113F priority Critical patent/JP1667072S/ja
Application granted granted Critical
Publication of JP1667072S publication Critical patent/JP1667072S/ja
Priority to TW109305311F priority patent/TWD212462S/zh
Priority to US29/752,054 priority patent/USD986175S1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JPD2020-6113F 2020-03-30 2020-03-30 Active JP1667072S (Direct)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JPD2020-6113F JP1667072S (Direct) 2020-03-30 2020-03-30
TW109305311F TWD212462S (zh) 2020-03-30 2020-09-21 信號變換器
US29/752,054 USD986175S1 (en) 2020-03-30 2020-09-24 Signal converter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JPD2020-6113F JP1667072S (Direct) 2020-03-30 2020-03-30

Publications (1)

Publication Number Publication Date
JP1667072S true JP1667072S (Direct) 2020-08-31

Family

ID=72240610

Family Applications (1)

Application Number Title Priority Date Filing Date
JPD2020-6113F Active JP1667072S (Direct) 2020-03-30 2020-03-30

Country Status (3)

Country Link
US (1) USD986175S1 (Direct)
JP (1) JP1667072S (Direct)
TW (1) TWD212462S (Direct)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD1091344S1 (en) * 2023-08-04 2025-09-02 Hossam Fattah Automotive on-board diagnostics cable
USD1078638S1 (en) * 2025-01-07 2025-06-10 Weifang Xingyuan Trading Co., Ltd. Variable frequency control device

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491472A (en) * 1993-12-28 1996-02-13 Kurtz; Fred R. RF switching with remote controllers dedicated to other devices
JPH10141841A (ja) 1996-11-08 1998-05-29 Matsushita Refrig Co Ltd 断熱箱体
USD432987S (en) * 1999-10-01 2000-10-31 Smc Kabushiki Kaisha Signal converter
USD443586S1 (en) * 1999-10-18 2001-06-12 Smc Kabushiki Kaisha Signal input/output converter
AU142324S (en) * 2000-01-25 2000-11-20 Sony Computer Entertainment Inc Connector
JP1573481S (Direct) 2016-10-13 2017-04-10
JP1601658S (Direct) * 2017-09-12 2018-04-09
JP1601264S (Direct) * 2017-09-12 2018-04-09
JP1601657S (Direct) * 2017-09-12 2018-04-09
JP1601263S (Direct) * 2017-09-12 2018-04-09
JP1641220S (Direct) * 2019-01-30 2019-09-17
JP1641221S (Direct) * 2019-01-30 2019-09-17
JP1641219S (Direct) * 2019-01-30 2019-09-17
JP1646193S (Direct) * 2019-05-09 2019-11-25
JP1659525S (Direct) * 2019-09-03 2020-05-18

Also Published As

Publication number Publication date
TWD212462S (zh) 2021-07-01
USD986175S1 (en) 2023-05-16

Similar Documents

Publication Publication Date Title
JP1667072S (Direct)
BR102021007058A2 (Direct)
BR102020022030A2 (Direct)
AR134288A1 (es) UN PÉPTIDO CÍCLICO PARA ATRAPAR LA INTERLEUCINA-1b
AR134282A1 (es) Compuestos y composiciones farmacéuticas que degradan el regulador de la subfamilia a de la cromatina dependiente de actina asociado a la matriz relacionado con swi / snf
AR134275A1 (es) Anticuerpos cd24
AR134276A1 (es) ANTICUERPOS ANTI-MIGIS-a Y MÉTODOS DE USO DE ESTOS
AR134271A1 (es) Variantes de cnp, conjugados y formulaciones de los mismos
AR134264A1 (es) Correctores farmacológicos de rodopsina y sus usos
AR134266A1 (es) Métodos para tratar el cáncer utilizando compuestos que inhiben la pkmyt1
AR134263A1 (es) Tratamiento de covid persistente con composición de vesículas extracelulares
AR134262A1 (es) Formulación líquida de agente biológico en almacenamiento estable
AR134257A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134258A1 (es) Degradadores bcl-xl heterobifuncionales de tetrahidroisoquinolina
AR134259A1 (es) Compuestos de pirimidina bicíclicos, métodos y usos de estos
AR134219A1 (es) Derivados de (piperidin-4-il)-1,5-naftiridina y (piperidin-4-il)quinolina sustituidos y usos de los mismos
AR134215A1 (es) Compuestos de tiazol y métodos de uso
AR134214A1 (es) Redireccionamiento de cápsides de aav para dirigirlas al sistema nervioso central
AR134200A1 (es) Combinaciones de herbicida / protector a base de herbicidas de la clase de las amidas de ácido n-(1,3,4-oxadiazol-2-il)fenilcarboxílico quirales y sus sales
AR134206A1 (es) Degradantes y usos de los mismos
AR134203A1 (es) Compuestos para la degradación de braf mutante
AR134198A1 (es) Compuestos de proteasa 1 de procesamiento específico de ubiquitina (usp1)
AR134194A1 (es) Nuevos moduladores de nitrato, amonio y potasio en plantas y métodos para usarlos
AR134193A1 (es) Métodos para tratar tumores tenosinoviales de células gigantes
AR134185A1 (es) Anticuerpos anti-receptor de transferrina y usos de estos